Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial

科研成果: 期刊稿件文章同行评审

42 引用 (Scopus)
源语言英语
页(从-至)815-824
页数10
期刊Journal of the American Academy of Dermatology
87
4
DOI
出版状态已出版 - 10月 2022
已对外发布

!!!ASJC Scopus Subject Areas

  • 皮肤医学

指纹

探究 'Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial' 的科研主题。它们共同构成独一无二的指纹。

引用此